Harmony Biosciences Holdings, Inc. (HRMY)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch HRMY
See up to 3 months of HRMY. The 7-day demo opens the 1M and 3M ranges and puts HRMY on your watchlist.
Start 7-day demoLatest HRMY insider trades
About Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. is an SEC registrant, filing under CIK 0001802665, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
HRMY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 72,406 | $3.11M |
| Option exercise | 16 | 122,812 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
HRMY insider transactions (Form 4)
9531 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kumar Budur - Officer | Option exercise | Common Stock | 900 | $30.69 | $28K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 900 | $30.27 | $27K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 1,800 | $43.01 footnote F2 | $77K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 400 | $30.69 | $12K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 400 | $30.27 | $12K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 800 | $43.00 | $34K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 10,406 | $30.69 | $319K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 25,446 | $30.27 | $770K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 35,852 | $43.05 footnote F3 | $1.54M | |
| Kumar Budur - Officer | Option exercise | Stock Option | 900 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 900 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 400 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 400 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 10,406 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 25,446 | $0.00 | - | |
| ||||||
| Kumar Budur - Officer | Open-market sale | Common Stock | 5,500 | $41.98 footnote F2 | $231K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 4,500 | $42.25 footnote F3 | $190K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 1,000 | $42.79 footnote F4 | $43K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 12,200 | $30.69 | $374K | |
| Kumar Budur - Officer | Option exercise | Common Stock | 10,754 | $30.27 | $326K | |
| Kumar Budur - Officer | Open-market sale | Common Stock | 22,954 | $43.10 footnote F5 | $989K | |
| Kumar Budur - Officer | Option exercise | Stock Option | 12,200 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Stock Option | 10,754 | $0.00 | - | |
| ||||||
| Geno J. Germano | Grant or award | Stock Option | 21,231 | $0.00 | - | |
 Linda M. Szyper | Grant or award | Stock Option | 21,872 | $0.00 | - | |
 Ron M. Philip | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| R. Mark Graf | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Juan A. Sabater | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Gary Sender | Grant or award | Stock Option | 21,872 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 18,750 | $0.00 | - | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 8,882 | $31.83 | $283K | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 18,750 | $0.00 | - | |
 Glenn Reicin - Officer | Grant or award | Stock Option | 164,309 | $0.00 | - | |
| Adam H. Zaeske - Officer | Option exercise | Common Stock | 7,500 | $0.00 | - | |
| Adam H. Zaeske - Officer | Tax withholding / forfeiture | Common Stock | 3,173 | $27.62 | $88K | |
| Adam H. Zaeske - Officer | Option exercise | Restricted Stock Units | 7,500 | $0.00 | - | |
| Peter Anastasiou - Officer | Grant or award | Stock Option | 212,241 | $0.00 | - | |
 Troy A. Ignelzi | Grant or award | Stock Option | 17,710 | $0.00 | - | |
 Sandip Kapadia - Officer | Open-market sale | Common Stock | 3,746 | $37.15 footnote F2 | $139K | |
| ||||||
| Sandip Kapadia - Officer | Option exercise | Common Stock | 3,813 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 4,725 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 2,239 | $36.82 | $82K | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 2,553 | $36.82 | $94K | |
| Sandip Kapadia - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Sandip Kapadia - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 3,813 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 4,725 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Common Stock | 2,500 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Common Stock | 2,600 | $0.00 | - | |
| Andrew Serafin - Officer | Tax withholding / forfeiture | Common Stock | 1,116 | $36.82 | $41K | |
| Andrew Serafin - Officer | Tax withholding / forfeiture | Common Stock | 1,126 | $36.82 | $41K | |
| Andrew Serafin - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Andrew Serafin - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Restricted Stock Units | 2,500 | $0.00 | - | |
| Andrew Serafin - Officer | Option exercise | Restricted Stock Units | 2,600 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 2,188 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Common Stock | 2,662 | $0.00 | - | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 1,153 | $36.82 | $42K | |
| Kumar Budur - Officer | Tax withholding / forfeiture | Common Stock | 1,372 | $36.82 | $51K | |
| Kumar Budur - Officer | Grant or award | Stock Option | 42,600 | $0.00 | - | |
| Kumar Budur - Officer | Grant or award | Restricted Stock Units | 12,200 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 2,188 | $0.00 | - | |
| Kumar Budur - Officer | Option exercise | Restricted Stock Units | 2,662 | $0.00 | - | |
| Adam H. Zaeske - Officer | Grant or award | Stock Option | 56,900 | $0.00 | - | |
| Adam H. Zaeske - Officer | Grant or award | Restricted Stock Units | 16,200 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Common Stock | 10,500 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Common Stock | 13,000 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Tax withholding / forfeiture | Common Stock | 4,785 | $36.82 | $176K | |
| Jeffrey M. Dayno - Officer | Tax withholding / forfeiture | Common Stock | 5,654 | $36.82 | $208K | |
| Jeffrey M. Dayno - Officer | Grant or award | Stock Option | 184,600 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Grant or award | Restricted Stock Units | 52,900 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Restricted Stock Units | 10,500 | $0.00 | - | |
| Jeffrey M. Dayno - Officer | Option exercise | Restricted Stock Units | 13,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 20,961 | $35.92 footnote F2 | $753K | |
| ||||||
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 3,427 | $35.00 | $120K | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 45,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 24,039 | $27.56 | $663K | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 45,000 | $0.00 | - | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Other | Common Stock | 6,618,033 | - | - | |
| Sandip Kapadia - Officer | Open-market sale | Common Stock | 21,573 | $36.50 | $787K | |
| Marshman Fund Trust II - 10% Owner | Open-market sale | Common Stock | 4,000,000 | $30.30 | $121.21M | |
| Marshman Fund Trust II - 10% Owner | Open-market sale | Common Stock | 600,000 | $30.30 | $18.18M | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Open-market sale | Common Stock | 4,000,000 | $30.30 | $121.21M | |
| Valor IV Pharma Holdings, LLC - 10% Owner | Open-market sale | Common Stock | 600,000 | $30.30 | $18.18M | |
| Jeffrey Dierks - Officer | Option exercise | Common Stock | 21,496 | $24.00 | $516K | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 21,496 | $40.47 | $870K | |
| Jeffrey Dierks - Officer | Option exercise | Stock Option | 21,496 | $0.00 | - | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 35,652 | $35.05 | $1.25M | |
| Jeffrey Dierks - Officer | Open-market sale | Common Stock | 705 | $35.62 | $25K | |
| Jeffrey Dierks - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Jeffrey Dierks - Officer | Tax withholding / forfeiture | Common Stock | 23,643 | $40.00 | $946K | |
| Jeffrey Dierks - Officer | Option exercise | Restricted Stock Units | 60,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Option exercise | Common Stock | 60,000 | $0.00 | - | |
| Sandip Kapadia - Officer | Tax withholding / forfeiture | Common Stock | 32,052 | $40.00 | $1.28M | |
| Sandip Kapadia - Officer | Option exercise | Restricted Stock Units | 60,000 | $0.00 | - | |
Item 5.02, 7.01, 9.01
Item 2.02, 7.01, 9.01
Item 2.02, 5.02, 7.01, 9.01
Item 5.07
Recent HRMY Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| KUMAR BUDUR | Officer | 35,852 | $1.53M | View on EDGAR | |
| KUMAR BUDUR | Officer | 800 | $34K |
HRMY insider trading FAQ
What is the latest insider trade for HRMY?
Harmony Biosciences Holdings, Inc. (HRMY) had 2 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for HRMY runs to 31 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying HRMY stock?
No insider purchases of HRMY were filed in the last 90 days.
How many insiders are selling HRMY stock?
7 insider sales of HRMY were filed in the last 90 days, totaling $3.11M.
Where can I see HRMY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects HRMY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kumar Budur view on EDGAR
- - Kumar Budur view on EDGAR
- - Geno J. Germano view on EDGAR
- - Linda M. Szyper view on EDGAR
- - Ron M. Philip view on EDGAR
- - R. Mark Graf view on EDGAR
- - Juan A. Sabater view on EDGAR
- - Gary Sender view on EDGAR
- - Kumar Budur view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where HRMY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow HRMY with a 7-day demo
- HRMY on your watchlist
- Every HRMY Form 4 filing on record
- Up to 3 months of HRMY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
